|
[1]
|
Huang, W., Goldberg, R.J., Anderson, F.A., et al. (2014) Secular Trends in Occurrence of Acute Venous Thromboem-bolism: The Worcester VTE Study (1985-2009). The American Journal of Medicine, 127, 829-839. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Basil, N., Ekstrm, M., Piitulainen, E., et al. (2021) Severe Al-pha-1-Antitrypsin Deficiency Increases the Risk of Venous Thromboembolism. Journal of Thrombosis and Haemosta-sis, 19, 1519-1525. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Fukaya, E., Flores, A.M., Lindholm, D., et al. (2018) Clinical and Genetic Determinants of Varicose Veins. Circulation, 138, 2869-2880. [Google Scholar] [CrossRef]
|
|
[4]
|
Griffin, J.H., Evatt, B., Zimmerman, T.S., et al. (1981) Deficiency of Protein C in Congenital Thrombotic Disease. Journal of Clinical Investigation, 68, 1370-1373. [Google Scholar] [CrossRef]
|
|
[5]
|
Fitzmaurice, D., Fletcher, K., Greenfield, S., et al. (2020) Prevention and Treatment of Venous Thromboembolism in Hospital and the Community: A Research Programme Including the ExACT RCT. Programme Grants for Applied Research, 8, 1-104. [Google Scholar] [CrossRef]
|
|
[6]
|
Ahmad, A., Sundquist, K., Palmer, K., et al. (2019) Risk Prediction of Recurrent Venous Thromboembolism: A Multiple Genetic Risk Model. Journal of Thrombosis and Thrombolysis, 47, 216-226. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Bucciarelli, P., Passamonti, S.M., Biguzzi, E., et al. (2012) Low Borderline Plasma Levels of Antithrombin, Protein C and Protein S Are Risk Factors for Venous Thromboembolism. Journal of Thrombosis and Haemostasis, 10, 1783-1791. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
中华医学会外科学会血管外科组. 深静脉血栓形成的诊断和治疗指南(第三版) [J]. 中华普通外科杂志, 2017, 32(9): 807-812.
|
|
[9]
|
邵翔, 司超增, 甄凯元, 等. 医院相关性静脉血栓栓塞症的临床特征及相关危险因素分析[J]. 中华血液学杂志, 2020, 100(20): 1539-1543.
|
|
[10]
|
Fukaya, E., Flores, A.M., Lindholm, D., et al. (2019) Clinical and Genetic Determinants of Varicose Veins: Prospective, Community-Based Study of ≈500000 Individuals. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 7, 283-284. [Google Scholar] [CrossRef]
|
|
[11]
|
Enden, T., Haig, Y., Klow, N.E., et al. (2012) Long-Term Outcome after Additional Catheter-Directed Thrombolysis versus Standard Treatment for Acute Iliofemoral Deep Vein Thrombosis (the CaVenT Study): A Randomised Controlled Trial. The Lancet, 379, 31-38. [Google Scholar] [CrossRef]
|
|
[12]
|
Sciascia, S., Baldovino, S., Schreiber, K., et al. (2016) Thrombotic Risk Assessment in Antiphospholipid Syndrome: The Role of New Antibody Specificities and Thrombin Generation Assay. Clinical and Molecular Allergy, 14, 6. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
车焱. 我国妇产科静脉血栓栓塞症发生率研究现状[J]. 中国实用妇科与产科杂志, 2018, 34(7): 709-713.
|
|
[14]
|
Bates, S.M., Jaeschke, R., Stevens, S.M., et al. (2012) Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest Journal, 141, 351-418. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Tinholt, M., Sandset, P.M., Iversen, N., et al. (2016) Polymorphisms of the Coagulation System and Risk of Cancer. Thrombosis Research, 140, 49-54. [Google Scholar] [CrossRef]
|
|
[16]
|
Souto, J.C., Almasy, L., Borrell, M., et al. (2000) Genetic Susceptibility to Thrombosis and Its Relationship to Physiological Risk Factors: The GAIT Study. The American Journal of Human Genetics, 67, 1452-1459. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Chung, D., Chen, J.M., Ling, M.H., et al. (2016) High-Density Lipoprotein Modulates Thrombosis by Preventing von Willebrand Factor Self-Association and Subsequent Platelet Adhesion. Blood, 127, 637-645. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Riva, N., Donadini, M.P. and Ageno, W. (2014) Epidemiology and Pathophysiology of Venous Thromboembolism: Similarities with Atherothrombosis and the Role of Inflammation. Thrombosis and Haemostasis, 13, 1176-1183.
|